Both in Pharmaceuticals
Bausch Health Companies vs Viridian Therapeutics
Over the past year BHC returned +19.5% and VRDN returned +8.6%; their daily moves had a correlation of 0.03.
BHC +19.5% VRDN +8.6%Growth of $1, one year, split-adjusted
| Metric | BHC | VRDN |
|---|---|---|
| Price | $8.14 | $25.15 |
| Market cap | $3.05B | $2.85B |
| Today | +1.50% | −0.59% |
| 1 month | +38.2% | +32.4% |
| 6 months | +44.3% | +34.1% |
| Year to date | +17.1% | −19.2% |
| 1 year | +16.0% | +6.4% |
| Revenue growth (YoY) | +9.7% | +278.7% |
| Gross margin | 75.0% | 100.0% |
| Net margin | 14.8% | −39726.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 40.1× |
| Net cash | -$18.15B | $625.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.8% | 47.3% |
| Short % of float | 3.1% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).